Across the whole pharma sector, there are four or five stocks big one out there which are going to gain market share. So, CDMO is one space within pharma which should do well as we go along. But pharma as a whole space per se has been doing okay and we continue to believe that incrementally also pharma should continue to do well in the coming year also.
Tata Motors, Ashok Leyland shares rocket up to 12%. Here are 2 reasons fuelling the sharp surge
Ashok Leyland and Tata Motors shares rallied, tracking a sharp fall in crude oil prices and a broader market recovery amid hopes of a negotiated
November 5, 2026